Correction to: Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis

Phyllis Chan; Jiajie Yu; Leslie Chinn; Marita Prohn; Jan Huisman; Brett Matzuka; William Hanley; Katie Tuckwell; Angelica Quartino

doi:10.1007/s11095-020-2761-x

Correction to: Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis

Pharm Res. 2020 Jan 24;37(3):41. doi: 10.1007/s11095-020-2761-x.

Authors

Phyllis Chan¹, Jiajie Yu², Leslie Chinn², Marita Prohn³, Jan Huisman³, Brett Matzuka⁴, William Hanley⁵, Katie Tuckwell⁶, Angelica Quartino²

Affiliations

¹ Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA. Chanchan.hui-min@gene.com.
² Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
³ qPharmetra, Nijmegen, Netherlands.
⁴ qPharmetra, Cary, North Carolina, USA.
⁵ Former Genentech employee, currently of Seattle Genetics, South San Francisco, California, USA.
⁶ Clinical Sciences, Early Clinical Development, Genentech, South San Francisco, California, USA.

Abstract

The article was published with an incomplete title. The complete title is "Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis" The original article has been corrected.

Publication types

Published Erratum